Erik A. Ranheim

4.1k total citations · 1 hit paper
92 papers, 2.8k citations indexed

About

Erik A. Ranheim is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Erik A. Ranheim has authored 92 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 31 papers in Oncology and 26 papers in Molecular Biology. Recurrent topics in Erik A. Ranheim's work include Lymphoma Diagnosis and Treatment (22 papers), Acute Myeloid Leukemia Research (19 papers) and Immune Cell Function and Interaction (16 papers). Erik A. Ranheim is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Acute Myeloid Leukemia Research (19 papers) and Immune Cell Function and Interaction (16 papers). Erik A. Ranheim collaborates with scholars based in United States, Canada and China. Erik A. Ranheim's co-authors include Thomas J. Kipps, Martin Lotz, Irving L. Weissman, Guangyao Kong, Jing Zhang, Israel Charo, Petra Hoffmann, Samuel Strober, Miriam Mérad and Sarah Slaymaker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Erik A. Ranheim

89 papers receiving 2.8k citations

Hit Papers

Activated T cells induce expression of B7/BB1 on normal o... 1993 2026 2004 2015 1993 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.
    1993 508 citations Erik A. Ranheim et al. profile →

Peers

Erik A. Ranheim
Wayne R. Godfrey United States
Krzysztof Giannopoulos Poland
Ursula Kapp Germany
Yoshikane Kikushige Japan
Johanna Olweus Norway
Bertrand Huard Switzerland
Clelia Tiziana Storlazzi Italy
Todd W. Kelley United States
Claudine Schiff France
Ranjani Rajapaksa United States
Wayne R. Godfrey United States
Erik A. Ranheim
Citations per year, relative to Erik A. Ranheim Erik A. Ranheim (= 1×) peers Wayne R. Godfrey

Countries citing papers authored by Erik A. Ranheim

Since Specialization
Citations

This map shows the geographic impact of Erik A. Ranheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik A. Ranheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik A. Ranheim more than expected).

Fields of papers citing papers by Erik A. Ranheim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik A. Ranheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik A. Ranheim. The network helps show where Erik A. Ranheim may publish in the future.

Co-authorship network of co-authors of Erik A. Ranheim

This figure shows the co-authorship network connecting the top 25 collaborators of Erik A. Ranheim. A scholar is included among the top collaborators of Erik A. Ranheim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik A. Ranheim. Erik A. Ranheim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Albertini, Mark R., Cindy Zuleger, Erik A. Ranheim, et al.. (2024). Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma. Melanoma Research. 34(4). 307–318. 3 indexed citations
3.
Nukaya, Manabu, et al.. (2023). Pdx1 expression in hematopoietic cells activates Kras -mutation to drive leukemia in KC ( Pdx1-Cre; LSL-Kras G12D/+ ) mice. Leukemia & lymphoma. 64(6). 1112–1122. 1 indexed citations
4.
Ranheim, Erik A., Daniel R. Matson, Yun Zhou, et al.. (2023). A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice. Journal of Clinical Investigation. 133(24). 10 indexed citations
5.
Wen, Zhi, Xin Gao, Lin Li, et al.. (2022). Tcof1 haploinsufficiency promotes early T cell precursor-like leukemia in NrasQ61R/+ mice. Leukemia. 36(4). 1167–1170. 1 indexed citations
6.
Ranheim, Erik A., et al.. (2022). Unsuspected systemic Epstein-Barr virus–positive T-cell lymphoma of childhood diagnosed at autopsy in a potential homicide case. Journal of Pathology and Translational Medicine. 57(2). 123–127. 1 indexed citations
7.
Evens, Andrew M., Fangxin Hong, Thomas M. Habermann, et al.. (2020). A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408. Clinical Cancer Research. 26(17). 4468–4477. 16 indexed citations
8.
Romero-Masters, James C., Shane M. Huebner, Makoto Ohashi, et al.. (2020). B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection. PLoS Pathogens. 16(2). e1008365–e1008365. 31 indexed citations
9.
Yang, Richard K., Igor B. Kuznetsov, Erik A. Ranheim, et al.. (2020). Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2. Clinical Cancer Research. 26(13). 3296–3306. 17 indexed citations
10.
Ranheim, Erik A.. (2018). Pearls and pitfalls in the diagnostic workup of small lymph node biopsies. Modern Pathology. 32(Suppl 1). 38–43. 5 indexed citations
11.
Zuleger, Cindy, Erik A. Ranheim, Ilene D. Kurzman, et al.. (2017). Pilot study of safety and feasibility of DNA microseeding for treatment of spontaneous canine melanoma. Veterinary Medicine and Science. 3(3). 134–145. 10 indexed citations
12.
13.
Albertini, Mark R., Erik A. Ranheim, Cindy Zuleger, et al.. (2016). Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma. Cancer Immunology Immunotherapy. 65(8). 897–907. 14 indexed citations
14.
Brooks, Erin G., et al.. (2016). Enhancing preclinical year pathology exposure: the Angevine approach. Human Pathology. 53. 58–62. 10 indexed citations
15.
Gao, Xin, et al.. (2016). GATA Factor-G-Protein-Coupled Receptor Circuit Suppresses Hematopoiesis. Stem Cell Reports. 6(3). 368–382. 10 indexed citations
16.
You, Xiaona, Guangyao Kong, Erik A. Ranheim, et al.. (2015). Loss of Dnmt3a and endogenous KrasG12D/+ cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis. Leukemia. 29(9). 1847–1856. 42 indexed citations
17.
Wu, Qingli, Ilia N. Buhtoiarov, Paul M. Sondel, Alexander L. Rakhmilevich, & Erik A. Ranheim. (2009). Tumoricidal Effects of Activated Macrophages in a Mouse Model of Chronic Lymphocytic Leukemia. The Journal of Immunology. 182(11). 6771–6778. 23 indexed citations
18.
Buhtoiarov, Ilia N., Alexander L. Rakhmilevich, Lewis L. Lanier, Erik A. Ranheim, & Paul M. Sondel. (2009). Naive Mouse Macrophages Become Activated following Recognition of L5178Y Lymphoma Cells via Concurrent Ligation of CD40, NKG2D, and CD18 Molecules. The Journal of Immunology. 182(4). 1940–1953. 12 indexed citations
19.
20.
Seroogy, Christine M., Luis Soares, Erik A. Ranheim, et al.. (2004). The Gene Related to Anergy in Lymphocytes, an E3 Ubiquitin Ligase, Is Necessary for Anergy Induction in CD4 T Cells. The Journal of Immunology. 173(1). 79–85. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wayne R. Godfrey Breakdown of academic impact, for papers by Krzysztof Giannopoulos Breakdown of academic impact, for papers by Ursula Kapp Breakdown of academic impact, for papers by Yoshikane Kikushige Breakdown of academic impact, for papers by Johanna Olweus Breakdown of academic impact, for papers by Bertrand Huard Breakdown of academic impact, for papers by Clelia Tiziana Storlazzi Breakdown of academic impact, for papers by Todd W. Kelley Breakdown of academic impact, for papers by Claudine Schiff Breakdown of academic impact, for papers by Ranjani Rajapaksa
Rankless by CCL
2026